Citations (52)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Steven L. Shipp, Mark A. Cline & Elizabeth R. Gilbert. (2016) Recent advances in the understanding of how neuropeptide Y and α-melanocyte stimulating hormone function in adipose physiology. Adipocyte 5:4, pages 333-350.
Read now
Read now
Nathalie Pop, Patrick Igel, Albert Brennauer, Chiara Cabrele, Günther Bernhardt, Roland Seifert & Armin Buschauer. (2011) Functional reconstitution of human neuropeptide Y (NPY) Y2 and Y4 receptors in Sf9 insect cells. Journal of Receptors and Signal Transduction 31:4, pages 271-285.
Read now
Read now
Articles from other publishers (50)
Corinna Schüß, Oanh Vu, Nigam M. Mishra, Iain R. Tough, Yu Du, Jan Stichel, Helen M. CoxC. David Weaver, Jens Meiler, Kyle A. Emmitte & Annette G. Beck-Sickinger. (2023)
Structure–Activity Relationship Study of the High-Affinity Neuropeptide Y
4
Receptor Positive Allosteric Modulator VU0506013
. Journal of Medicinal Chemistry 66:13, pages 8745-8766.
Crossref
Crossref
Giovanna Ponti, Elisabetta Bo, Brigitta Bonaldo, Alice Farinetti, Marilena Marraudino, Giancarlo Panzica & Stefano Gotti. (2022) Perinatal exposure to tributyltin affects feeding behavior and expression of hypothalamic neuropeptide Y in the paraventricular nucleus of adult mice. Journal of Anatomy 242:2, pages 235-244.
Crossref
Crossref
Tingting Tang, Qiuxiang Tan, Shuo Han, Anne Diemar, Kristin LöbnerHongyu WangCorinna Schüß, Victoria Behr, Karin Mörl, Mu Wang, Xiaojing Chu, Cuiying Yi, Max Keller, Jacob KofoedSteffen Reedtz-Runge, Anette Kaiser, Annette G. Beck-Sickinger, Qiang Zhao & Beili Wu. (2022) Receptor-specific recognition of NPY peptides revealed by structures of NPY receptors. Science Advances 8:18.
Crossref
Crossref
Miron Mikhailowitsch Gershkovich, Victoria Elisabeth Groß, Oanh Vu, Clara Tabea Schoeder, Jens Meiler, Simone Prömel & Anette Kaiser. (2021) Structural Perspective on Ancient Neuropeptide Y-like System reveals Hallmark Features for Peptide Recognition and Receptor Activation. Journal of Molecular Biology 433:13, pages 166992.
Crossref
Crossref
Weixia Zhong, Omar Shahbaz, Garrett Teskey, Abrianna Beever, Nala Kachour, Vishwanath Venketaraman & Nissar A. Darmani. (2021) Mechanisms of Nausea and Vomiting: Current Knowledge and Recent Advances in Intracellular Emetic Signaling Systems. International Journal of Molecular Sciences 22:11, pages 5797.
Crossref
Crossref
Corinna Schüß, Oanh Vu, Mario Schubert, Yu Du, Nigam M. Mishra, Iain R. ToughJan Stichel, C. David Weaver, Kyle A. Emmitte, Helen M. CoxJens Meiler & Annette G. Beck-Sickinger. (2021)
Highly Selective Y
4
Receptor Antagonist Binds in an Allosteric Binding Pocket
. Journal of Medicinal Chemistry 64:5, pages 2801-2814.
Crossref
Crossref
Tingting Tang, Christin Hartig, Qiuru Chen, Wenli Zhao, Anette Kaiser, Xuefeng Zhang, Hui Zhang, Honge Qu, Cuiying Yi, Limin Ma, Shuo Han, Qiang Zhao, Annette G. Beck-Sickinger & Beili Wu. (2021) Structural basis for ligand recognition of the neuropeptide Y Y2 receptor. Nature Communications 12:1.
Crossref
Crossref
A. I. Khavkin, O. P. Gurina, E. A. Dementieva, A. E. Blinov & O. N. Varlamova. (2020) Modern possibilities of laboratory diagnosis of disorders of the gastrointestinal tract. Experimental and Clinical Gastroenterology:6, pages 173-185.
Crossref
Crossref
Rachel R. RichardsonMarleen GroenenMengjie Liu, Simon J. Mountford, Stephen J. BriddonNicholas D. Holliday & Philip E. Thompson. (2020) Heterodimeric Analogues of the Potent Y1R Antagonist 1229U91, Lacking One of the Pharmacophoric C-Terminal Structures, Retain Potent Y1R Affinity and Show Improved Selectivity over Y4R. Journal of Medicinal Chemistry 63:10, pages 5274-5286.
Crossref
Crossref
Kyle W. Sloop, Daniel A. Briere, Paul J. Emmerson & Francis S. Willard. (2018) Beyond Glucagon-like Peptide-1: Is G-Protein Coupled Receptor Polypharmacology the Path Forward to Treating Metabolic Diseases?. ACS Pharmacology & Translational Science 1:1, pages 3-11.
Crossref
Crossref
Jianlong Han, Jinliang Zuo, Dengsong Zhu & Chunzheng Gao. (2017)
The correlation between
SNP
s within the gene of adrenergic receptor and neuropeptide Y and risk of cervical vertigo
. Journal of Clinical Laboratory Analysis 32:5.
Crossref
Crossref
Bo Xu, Silvana Vasile, Søren Østergaard, Johan F. Paulsson, Jasna Pruner, Johan Åqvist, Birgitte S. Wulff, Hugo Gutiérrez-de-Terán & Dan Larhammar. (2018)
Elucidation of the Binding Mode of the Carboxyterminal Region of Peptide YY to the Human Y
2
Receptor
. Molecular Pharmacology 93:4, pages 323-334.
Crossref
Crossref
Mario Schubert, Jan Stichel, Yu Du, Iain R. ToughGregory Sliwoski, Jens Meiler, Helen M. CoxC. David Weaver & Annette G. Beck-Sickinger. (2017)
Identification and Characterization of the First Selective Y
4
Receptor Positive Allosteric Modulator
. Journal of Medicinal Chemistry 60:17, pages 7605-7612.
Crossref
Crossref
Vignesh Shettar, Sarang Patel & Srividya Kidambi. (2017) Epidemiology of Obesity and Pharmacologic Treatment Options. Nutrition in Clinical Practice 32:4, pages 441-462.
Crossref
Crossref
Lizzy Wanka, Stefanie Babilon, Kerstin Burkert, Karin Mörl, Vsevolod V. Gurevich & Annette G. Beck-Sickinger. (2017) C-terminal motif of human neuropeptide Y4 receptor determines internalization and arrestin recruitment. Cellular Signalling 29, pages 233-239.
Crossref
Crossref
Anders Lehmann, Udo Bauer, Stephan Hjorth, Rudolph L. Leibel & Michael Rosenbaum. 2016. Neuroendocrinology of Appetite. Neuroendocrinology of Appetite
247
284
.
Gregory Sliwoski, Mario Schubert, Jan Stichel, David Weaver, Annette G. Beck-Sickinger & Jens Meiler. (2016) Discovery of Small-Molecule Modulators of the Human Y4 Receptor. PLOS ONE 11:6, pages e0157146.
Crossref
Crossref
Mathias Hallberg. (2015) Neuropeptides: Metabolism to Bioactive Fragments and the Pharmacology of Their Receptors. Medicinal Research Reviews 35:3, pages 464-519.
Crossref
Crossref
Michael Wilkinson & Richard E. Brown. 2015. An Introduction to Neuroendocrinology. An Introduction to Neuroendocrinology
257
285
.
Karin Mörl & Annette G. Beck-Sickinger. 2015. Trafficking of GPCRs. Trafficking of GPCRs
73
96
.
Dante Merlino, Erik Blomain, Amanda Aing & Scott Waldman. (2014) Gut-Brain Endocrine Axes in Weight Regulation and Obesity Pharmacotherapy. Journal of Clinical Medicine 3:3, pages 763-794.
Crossref
Crossref
Eugen Kloster, Carsten Saft, Denis A. Akkad, Jörg T. Epplen & Larissa Arning. (2013) Association of age at onset in Huntington disease with functional promoter variations in NPY and NPY2R. Journal of Molecular Medicine 92:2, pages 177-184.
Crossref
Crossref
Simon J. Mountford, Mengjie Liu, Lei Zhang, Marleen Groenen, Herbert Herzog, Nicholas D. Holliday & Philip E. Thompson. (2014) Synthetic routes to the Neuropeptide Y Y1 receptor antagonist 1229U91 and related analogues for SAR studies and cell-based imaging. Org. Biomol. Chem. 12:20, pages 3271-3281.
Crossref
Crossref
Stefanie Babilon, Karin Mörl & Annette G. Beck-Sickinger. (2013) Towards improved receptor targeting: anterograde transport, internalization and postendocytic trafficking of neuropeptide Y receptors. bchm 394:8, pages 921-936.
Crossref
Crossref
Wenying Chai, Victoria D. Wong, Diane Nepomuceno, Pascal Bonaventure, Timothy W. Lovenberg & Nicholas I. Carruthers. (2013) The discovery of potent selective NPY Y2 antagonists. Bioorganic & Medicinal Chemistry Letters 23:14, pages 4141-4144.
Crossref
Crossref
Per M. Hellström. (2013) Satiety signals and obesity. Current Opinion in Gastroenterology 29:2, pages 222-227.
Crossref
Crossref
Yih-Shou Hsieh, Pei-Ni Chen, Meng-Hsien Kuo & Dong-Yih Kuo. (2012) Neuropeptide Y Y1 receptor knockdown can modify glutathione peroxidase and c-AMP response element-binding protein in phenylpropanolamine-treated rats. Archives of Toxicology 87:3, pages 469-479.
Crossref
Crossref
Margit Pissarek & Ulrich Disko. (2013) Non-peptide ligands in the characterization of peptide receptors at the interface between neuroendocrine and mental diseases. World Journal of Neuroscience 03:02, pages 100-125.
Crossref
Crossref
Emil F. Coccaro, Royce Lee, Tianmin Liu & Aleksander A. Mathé. (2012) Cerebrospinal Fluid Neuropeptide Y-like Immunoreactivity Correlates with Impulsive Aggression in Human Subjects. Biological Psychiatry 72:12, pages 997-1003.
Crossref
Crossref
Shigeyuki Chaki & Kosuke Kanuma. 2012. Drug Discovery for Psychiatric Disorders. Drug Discovery for Psychiatric Disorders
300
330
.
Nicholas P. Barton & Benjamin R. Bellenie. 2012. Bioisosteres in Medicinal Chemistry. Bioisosteres in Medicinal Chemistry
199
215
.
Verena M Ahrens, Kathrin Bellmann-Sickert & Annette G Beck-Sickinger. (2012) Peptides and peptide conjugates: therapeutics on the upward path. Future Medicinal Chemistry 4:12, pages 1567-1586.
Crossref
Crossref
Gopi Kumar Mittapalli, Danielle Vellucci, Jun Yang, Marion Toussaint, Shaun P. Brothers, Claes Wahlestedt & Edward Roberts. (2012) Synthesis and SAR of selective small molecule neuropeptide Y Y2 receptor antagonists. Bioorganic & Medicinal Chemistry Letters 22:12, pages 3916-3920.
Crossref
Crossref
Jill L. Maron, Kirby L. Johnson, Jessica A. Dietz, Minghua L. Chen & Diana W. Bianchi. (2012) Neuropeptide Y2 Receptor (NPY2R) Expression in Saliva Predicts Feeding Immaturity in the Premature Neonate. PLoS ONE 7:5, pages e37870.
Crossref
Crossref
Lydiane Funkelstein, W. Douglas Lu, Britta Koch, Charles Mosier, Thomas Toneff, Laurent Taupenot, Daniel T. O'Connor, Thomas Reinheckel, Christoph Peters & Vivian Hook. (2012) Human Cathepsin V Protease Participates in Production of Enkephalin and NPY Neuropeptide Neurotransmitters. Journal of Biological Chemistry 287:19, pages 15232-15241.
Crossref
Crossref
Michael Fichtner, Eunsun Lee, Elizabeth Tomlinson, Dennis Scott, Peter Cornelius, Terrell A. Patterson & Philip A. Carpino. (2012) Discovery and evaluation of spirocyclic derivatives as antagonists of the neuropeptide Y5 receptor. Bioorganic & Medicinal Chemistry Letters 22:8, pages 2738-2743.
Crossref
Crossref
Shuanghua Hu, Yazhong Huang, Milind Deshpande, Guanglin Luo, Marc A. Bruce, Ling Chen, Gail Mattson, Lawrence G. Iben, Jie Zhang, John W. Russell, Wendy J. Clarke, John B. Hogan, Astrid Ortiz, Oliver Flint, Andrew Henwood, Qi Gao, Ildiko Antal-Zimanyi & Graham S. Poindexter. (2012) Discovery of a Novel Class of Bicyclo[3.1.0]hexanylpiperazines as Noncompetitive Neuropeptide Y Y1 Antagonists. ACS Medicinal Chemistry Letters 3:3, pages 222-226.
Crossref
Crossref
Lingyun Wu, Kai Lu, Mathivanan Packiarajan, Vrej Jubian, Gamini Chandrasena, Toni C. Wolinsky & Mary W. Walker. (2012) Indolyl and dihydroindolyl N-glycinamides as potent and in vivo active NPY5 antagonists. Bioorganic & Medicinal Chemistry Letters 22:6, pages 2167-2171.
Crossref
Crossref
Fang Xie, Rong Zhang, Chao Yang, Yi Xu, Ning Wang, Lihua Sun, Jing Liu, Luyao Sun, Ran Wei & Jing Ai. (2012) Long-term Neuropeptide Y Administration in the Periphery Induces Abnormal Baroreflex Sensitivity and Obesity in Rats. Cellular Physiology and Biochemistry 29:1-2, pages 111-120.
Crossref
Crossref
Mary Ann Pelleymounter, Yuren Wang & Ning Lee. 2011. Peptide Drug Discovery and Development. Peptide Drug Discovery and Development
245
268
.
Devin M. Swanson, Victoria D. Wong, Jill A. Jablonowski, Chandra Shah, Dale A. Rudolph, Curt A. Dvorak, Mark Seierstad, Lisa K. Dvorak, Kirsten Morton, Diane Nepomuceno, John R. Atack, Pascal Bonaventure, Timothy W. Lovenberg & Nicholas I. Carruthers. (2011) The discovery and synthesis of JNJ 31020028, a small molecule antagonist of the Neuropeptide Y Y2 receptor. Bioorganic & Medicinal Chemistry Letters 21:18, pages 5552-5556.
Crossref
Crossref
Lingyun Wu, Kai Lu, Mahesh Desai, Mathivanan Packiarajan, Amita Joshi, Mohammad R. Marzabadi, Vrej Jubian, Kim Andersen, Gamini Chandrasena, Noel J. Boyle & Mary W. Walker. (2011) N-Heteroaryl glycinamides and glycinamines as potent NPY5 antagonists. Bioorganic & Medicinal Chemistry Letters 21:18, pages 5573-5576.
Crossref
Crossref
Helena Fällmar, Helena Åkerberg, Hugo Gutiérrez-de-Terán, Ingrid Lundell, Nina Mohell & Dan Larhammar. (2011) Identification of positions in the human neuropeptide Y/peptide YY receptor Y2 that contribute to pharmacological differences between receptor subtypes. Neuropeptides 45:4, pages 293-300.
Crossref
Crossref
Ingrid Lundell, Nadine Rabe Bernhardt, Anna-Karin Johnsson & Dan Larhammar. (2011) Internalization studies of chimeric neuropeptide Y receptors Y1 and Y2 suggest complex interactions between cytoplasmic domains. Regulatory Peptides 168:1-3, pages 50-58.
Crossref
Crossref
Cornelia Walther, Karin Mörl & Annette G. Beck-Sickinger. (2011) Neuropeptide Y receptors: ligand binding and trafficking suggest novel approaches in drug development. Journal of Peptide Science 17:4, pages 233-246.
Crossref
Crossref
Gillian E. Lunniss, Ashley A. Barnes, Nick Barton, Matteo Biagetti, Federica Bianchi, Stephen M. Blowers, Laura L. Caberlotto, Amanda Emmons, Ian P. Holmes, Dino Montanari, Roz Norris, Gemma V. Puckey, Dewi J. Walters, Steve P. Watson & John Willis. (2010) The identification of a series of novel, soluble non-peptidic neuropeptide Y Y2 receptor antagonists. Bioorganic & Medicinal Chemistry Letters 20:24, pages 7341-7344.
Crossref
Crossref
Fayi Yao & Robert George MacKenzie. (2010) Obesity Drug Update: The Lost Decade?. Pharmaceuticals 3:12, pages 3494-3521.
Crossref
Crossref
R.J. Rodgers, P. Holch & A.J. Tallett. (2010) Behavioural satiety sequence (BSS): Separating wheat from chaff in the behavioural pharmacology of appetite. Pharmacology Biochemistry and Behavior 97:1, pages 3-14.
Crossref
Crossref
Shaun P. Brothers & Claes Wahlestedt. (2010) Therapeutic potential of neuropeptide Y (NPY) receptor ligands. EMBO Molecular Medicine 2:11, pages 429-439.
Crossref
Crossref
Matteo Biagetti, Colin Philip Leslie, Angelica Mazzali, Catia Seri, Domenica Antonia Pizzi, Jonathan Bentley, Thorsten Genski, Romano Di Fabio, Laura Zonzini & Laura Caberlotto. (2010) Synthesis and structure–activity relationship of N-(3-azabicyclo[3.1.0]hex-6-ylmethyl)-5-(2-pyridinyl)-1,3-thiazol-2-amines derivatives as NPY Y5 antagonists. Bioorganic & Medicinal Chemistry Letters 20:16, pages 4741-4744.
Crossref
Crossref